Moreover, the use of the emerging liquid biopsy even to identify HER2 status in CRC from circulating tumor DNA (ctDNA) represents an attractive future diagnostic tool [111,112,113], but it requires further investigations. The gene discussed is ERBB2; the disease is neoplasm.